However, the administration of HU308 for the selective activation of CB2 significantly attenuated the decrease of beclin-1 and LC3-II/I ratio and increase of p62 compared with the DCM group (Figures 2A,B). The gene discussed is BECN1; the disease is familial dilated cardiomyopathy.